If you would like to learn more about future focusIR related events and roundtables, please submit your details here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksRenold Regulatory News (RNO)

  • This share is currently suspended. It was suspended at a price of 81.80
  • There is currently no data for RNO

Director/PDMR Shareholding

24 Jan 2023 15:09

RNS Number : 7310N
Renold PLC
24 January 2023
 

 

24 January 2023

 

Renold plc

("Renold" or the "Company")

 

Director/PDMR Shareholding

 

Renold plc, a leading international supplier of industrial chains and related power transmission products, announces the exercise of share options under the Company's 2013 Performance Share Plan by Robert Purcell, Chief Executive of the Company.

 

Robert Purcell exercised nil cost options over 1,065,089 ordinary shares of 5 pence each in the capital of the Company ("Ordinary Shares"). The exercise of options will be satisfied by the transfer to Mr Purcell of 1,065,089 Ordinary Shares from the Renold Employee Benefit Trust.

 

Following this transaction, Mr Purcell, including the beneficial holdings of persons closely associated with him, has an interest in 5,808,878 Ordinary Shares, representing 2.58% of the Company's issued ordinary share capital.

 

ENQUIRIES:

Renold plc 

0161 498 4500

Robert Purcell, Chief Executive

 

Jim Haughey, Group Finance Director

 

 

Peel Hunt LLP (Nominated Adviser and Joint Broker)

020 7418 8900

 

Mike Bell

 

 

Ed Allsopp

 

 

 

finnCap Limited (Joint Broker)

020 7220 0500

 

Ed Frisby / Tim Harper (Corporate Finance)

 

 

Andrew Burdis / Harriet Ward (ECM)

 

 

 

 

IFC Advisory Limited (Financial PR and IR)

020 3934 6630

 

Tim Metcalfe

renold@investor-focus.co.uk

 

Graham Herring

 

 

 

NOTES FOR EDITORS

 

Renold is a global leader in the manufacture of industrial chains and also manufactures a range of torque transmission products which are sold throughout the world to a broad range of original equipment manufacturers and distributors. The Company has a well-deserved reputation for quality that is recognised worldwide. Its products are used in a wide variety of industries including manufacturing, transportation, energy, steel and mining.

 

Further information about Renold can be found on the website at: www.renold.com

 

 

The information below (set out in accordance with the requirements of EU Market Abuse Regulation) provides further detail:

 

1

 

Details of the person discharging managerial responsibilities / person closely associated

a)

Name

Robert Purcell

2

Reason for the notification

a)

Position/status

Chief Executive

b)

Initial notification /Amendment

Initial notification

3

 

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a)

Name

Renold plc

 

b)

LEI

213800LNDGJY65SP6P54

 

4

 

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

 

Description of the financial instrument, type of instrument

Ordinary Shares

Identification code

ISIN: GB0007325078

b)

Nature of the transaction

Exercise of nil cost Company Share Option Plan options (granted in 2016) over Ordinary Shares in Renold Plc

c)

 

Price(s) and volume(s)

Exercise Price

Volume

Nil

1,065,089

d)

 

Aggregated information

- Aggregated volume

1,065,089 Ordinary Shares

- Price

 Nil

e)

 

Date of the transaction

 

24 January 2023

f)

 

Place of the transaction

 

Outside of a trading platform

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
DSHBUGDBRGDDGXS
Date   Source Headline
12th Jul 20237:00 amRNSResults for the year ended 31 March 2023
10th Jul 20237:00 amRNSInvestor Presentation
19th Jun 20239:30 amRNSBlock Listing Six Monthly Return
18th May 20237:00 amRNSPreference Stock Dividend
9th May 20237:00 amRNSExtension of banking facilities
3rd May 202311:09 amRNSHolding(s) in Company
17th Apr 20237:00 amRNSTrading Update and Notice of Results
28th Mar 202312:53 pmRNSHolding(s) in Company
9th Mar 20237:00 amRNSNotice of Capital Markets Day
23rd Feb 202312:09 pmRNSHolding(s) in Company
10th Feb 20232:07 pmRNSHolding(s) in Company
8th Feb 20237:00 amRNSTrading Update
25th Jan 202310:00 amRNSHolding(s) in Company
24th Jan 20233:09 pmRNSDirector/PDMR Shareholding
17th Jan 20237:00 amRNSContract Win
19th Dec 20227:00 amRNSBlock Listing Six Monthly Return
8th Dec 20227:00 amRNSHolding(s) in Company
24th Nov 20225:18 pmRNSPreference Stock Dividend
16th Nov 20227:00 amRNSInterim Results
3rd Nov 20227:00 amRNSNotice of Results and Investor Presentation
12th Oct 20229:12 amRNSHolding(s) in Company
5th Oct 20224:10 pmRNSHolding(s) in Company
20th Sep 202212:34 pmRNSGrant of Options
9th Sep 202211:37 amRNSDirector/PDMR Shareholding
6th Sep 202212:13 pmRNSResult of AGM
6th Sep 20227:00 amRNSAGM Trading Update
4th Aug 20227:30 amRNS2022 Annual Report & Notice of AGM
4th Aug 20227:00 amRNSAcquisition of Industrias YUK S.A.
13th Jul 20227:00 amRNSFinal results for the year ended 31 March 2022
8th Jul 20227:00 amRNSInvestor presentation
17th Jun 20227:00 amRNSBlock Listing Six Monthly Return
18th May 202212:18 pmRNSPreference Stock Dividend
4th May 20227:00 amRNSAppointment of Non-Executive Director
19th Apr 20223:53 pmRNSHolding(s) in Company
14th Apr 20227:00 amRNSTrading Update and Notice of Results
2nd Feb 20224:35 pmRNSPrice Monitoring Extension
25th Jan 20229:23 amRNSHolding(s) in Company
20th Jan 20224:42 pmRNSSecond Price Monitoring Extn
20th Jan 20224:36 pmRNSPrice Monitoring Extension
20th Dec 202111:10 amRNSHolding(s) in Company
17th Dec 20218:43 amRNSBlock Listing Six Monthly Return
29th Nov 20213:15 pmRNSHolding(s) in Company
10th Nov 20217:00 amRNSInterim Results
8th Nov 20217:00 amRNSPreference Stock Dividend
5th Nov 20217:00 amRNSAppointment of Joint Broker
2nd Nov 202111:07 amRNSHolding(s) in Company
1st Nov 20211:04 pmRNSHolding(s) in Company
27th Oct 20217:00 amRNSNotice of Interim Results
20th Oct 20213:48 pmRNSHolding(s) in Company
31st Aug 202111:50 amRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.